[2] [7] These findings led regulatory authorities, including the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA), to include specific warnings and precautions in the prescribing information for all GLP-1 medications
Jeff Atlas, PA-C, works through each patients history, goals, and bloodwork before any treatment plan begins
Gut-Brain Axis Support Interestingly, BPC-157 may also support the gut-brain connection by modulating neurotransmitter systems like serotonin and dopamine, which influence both gut function and mental health
Thyroid cancer and insulin resistance
As a result, GLP-1 coverage for medically accepted FDA-approved indications other than obesity is required while access to GLP-1s to treat obesity under Medicaid is currently limited